SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-15-000157
Filing Date
2015-11-09
Accepted
2015-11-09 16:47:26
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jazz2015q3doc.htm 10-Q 1703789
2 AMENDED AND RESTATED OFFER LETTER jazzq32015ex101.htm EX-10.1 30848
3 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq32015ex311.htm EX-31.1 12902
4 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq32015ex312.htm EX-31.2 12092
5 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq32015ex321.htm EX-32.1 8060
  Complete submission text file 0001232524-15-000157.txt   7862044

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jazz-20150930.xml EX-101.INS 1637541
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20150930.xsd EX-101.SCH 51543
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20150930_cal.xml EX-101.CAL 112861
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20150930_def.xml EX-101.DEF 248104
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20150930_lab.xml EX-101.LAB 696846
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20150930_pre.xml EX-101.PRE 406776
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 151216323
SIC: 2834 Pharmaceutical Preparations